InsidersTradesSigma
Kinnate Biopharma Inc.: insider trades · United States · SEC (Form 4)
SEC:kinnate-biopharma-inc-c9714dUS·SEC (Form 4)
Discover the full directors' dealings record of Kinnate Biopharma Inc., a publicly traded company based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). The latest transaction was reported on 15 March 2022 — Acquisition. Among the most active insiders: Williams Richard Thomas. All data is free.
3
Insider Decl.
0
Thresholds
€3m
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
Last declaration on 15 March 2022
Declarations3 total
Executives▲Purchase38SEC
€117,66915,000 shares@ €7.8446100.0% of flow
Common Stock
SEC:0001209191-22-018866:0·
Ideal exit: 6 Dec 2022 (T+270)
Executives▲Purchase38SEC
€1m156,000 shares@ €8.9527100.0% of flow
Common Stock
SEC:0000947871-22-000255:0·
Ideal exit: 8 Nov 2022 (T+270)
Executives▲Purchase38SEC
€1m156,000 shares@ €8.9527100.0% of flow
Common Stock
SEC:0000947871-22-000254:0·
Ideal exit: 8 Nov 2022 (T+270)
3 of 3 declarations